BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 26490693)

  • 1. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
    Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
    Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombus age, clinical presentation, and reperfusion grade in myocardial infarction.
    Carol A; Bernet M; Curós A; Rodríguez-Leor O; Serra J; Fernández-Nofrerías E; Mauri J; Bayes-Genís A
    Cardiovasc Pathol; 2014; 23(3):126-30. PubMed ID: 24582379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method.
    Higashikata T; Yamagishi M; Higashi T; Nagata I; Iihara K; Miyamoto S; Ishibashi-Ueda H; Nagaya N; Iwase T; Tomoike H; Sakamoto A
    Atherosclerosis; 2006 Mar; 185(1):165-72. PubMed ID: 16039658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unloading the infarcted heart affect MMPs-TIMPs axis in a rat cardiac heterotopic transplantation model.
    Wang WJ; Meng ZL; Mo YC; Liu JW; Sun CC; Hu SS; Zhang H
    Mol Biol Rep; 2012 Jan; 39(1):277-83. PubMed ID: 21559840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human coronary thrombus formation is associated with degree of plaque disruption and expression of tissue factor and hexokinase II.
    Okuyama N; Matsuda S; Yamashita A; Moriguchi-Goto S; Sameshima N; Iwakiri T; Matsuura Y; Sato Y; Asada Y
    Circ J; 2015; 79(11):2430-8. PubMed ID: 26346032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time dependent apoptotic rates in the evolving coronary thrombus mass of myocardial infarction patients.
    Maagdenberg CG; de Boer OJ; Li X; Mackaay C; Niessen HW; de Winter RJ; Van der Wal AC
    Thromb Res; 2016 Sep; 145():12-7. PubMed ID: 27423322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
    Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
    Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates.
    Suzuki J; Isobe M; Kawauchi M; Endoh M; Amano J; Takamoto S
    Transpl Int; 2000; 13(2):106-13. PubMed ID: 10836646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset of endothelial cell proliferation in coronary thrombi of patients with an acute myocardial infarction: implications for plaque healing.
    Li X; Kramer MC; VAN DER Loos CM; Ploegmakers HJ; DE Boer OJ; Koch KT; Tijssen JG; DE Winter RJ; VAN DER Wal AC
    J Thromb Haemost; 2012 Mar; 10(3):466-73. PubMed ID: 22235978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
    Shukla V; Kumar Shakya A; Dhole TN; Misra UK
    Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1.
    Ma C; Tarnuzzer RW; Chegini N
    Wound Repair Regen; 1999; 7(6):477-85. PubMed ID: 10633007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
    Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.
    López-López N; González-Curiel I; Treviño-Santa Cruz MB; Rivas-Santiago B; Trujillo-Paez V; Enciso-Moreno JA; Serrano CJ
    Arch Dermatol Res; 2014 Nov; 306(9):809-21. PubMed ID: 25168880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
    Guenzinger R; Lahm H; Wottke M; Lange R
    ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.